238 related articles for article (PubMed ID: 21987580)
1. Centrifugal expansion of fundus autofluorescence patterns in Stargardt disease over time.
Cukras CA; Wong WT; Caruso R; Cunningham D; Zein W; Sieving PA
Arch Ophthalmol; 2012 Feb; 130(2):171-9. PubMed ID: 21987580
[TBL] [Abstract][Full Text] [Related]
2. Multimodal imaging and multifocal electroretinography demonstrate autosomal recessive Stargardt disease may present like occult macular dystrophy.
Sisk RA; Leng T
Retina; 2014 Aug; 34(8):1567-75. PubMed ID: 24743636
[TBL] [Abstract][Full Text] [Related]
3. A longitudinal study of Stargardt disease: quantitative assessment of fundus autofluorescence, progression, and genotype correlations.
Fujinami K; Lois N; Mukherjee R; McBain VA; Tsunoda K; Tsubota K; Stone EM; Fitzke FW; Bunce C; Moore AT; Webster AR; Michaelides M
Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8181-90. PubMed ID: 24265018
[TBL] [Abstract][Full Text] [Related]
4. Fundus autofluorescence in the Abca4(-/-) mouse model of Stargardt disease--correlation with accumulation of A2E, retinal function, and histology.
Charbel Issa P; Barnard AR; Singh MS; Carter E; Jiang Z; Radu RA; Schraermeyer U; MacLaren RE
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5602-12. PubMed ID: 23761084
[TBL] [Abstract][Full Text] [Related]
5. Mutations in GPR143/OA1 and ABCA4 Inform Interpretations of Short-Wavelength and Near-Infrared Fundus Autofluorescence.
Paavo M; Zhao J; Kim HJ; Lee W; Zernant J; Cai C; Allikmets R; Tsang SH; Sparrow JR
Invest Ophthalmol Vis Sci; 2018 May; 59(6):2459-2469. PubMed ID: 29847651
[TBL] [Abstract][Full Text] [Related]
6. Foveal sparing in Stargardt disease.
van Huet RA; Bax NM; Westeneng-Van Haaften SC; Muhamad M; Zonneveld-Vrieling MN; Hoefsloot LH; Cremers FP; Boon CJ; Klevering BJ; Hoyng CB
Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7467-78. PubMed ID: 25324290
[TBL] [Abstract][Full Text] [Related]
7. Progression of Stargardt Disease as Determined by Fundus Autofluorescence in the Retrospective Progression of Stargardt Disease Study (ProgStar Report No. 9).
Strauss RW; Muñoz B; Ho A; Jha A; Michaelides M; Cideciyan AV; Audo I; Birch DG; Hariri AH; Nittala MG; Sadda S; West S; Scholl HPN;
JAMA Ophthalmol; 2017 Nov; 135(11):1232-1241. PubMed ID: 29049437
[TBL] [Abstract][Full Text] [Related]
8. Progression of Late-Onset Stargardt Disease.
Lambertus S; Lindner M; Bax NM; Mauschitz MM; Nadal J; Schmid M; Schmitz-Valckenberg S; den Hollander AI; Weber BH; Holz FG; van der Wilt GJ; Fleckenstein M; Hoyng CB;
Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5186-5191. PubMed ID: 27699414
[TBL] [Abstract][Full Text] [Related]
9. Fundus autofluorescence (488 NM) and near-infrared autofluorescence (787 NM) visualize different retinal pigment epithelium alterations in patients with age-related macular degeneration.
Kellner U; Kellner S; Weinitz S
Retina; 2010 Jan; 30(1):6-15. PubMed ID: 20066766
[TBL] [Abstract][Full Text] [Related]
10. Incidence of Atrophic Lesions in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 5.
Strauss RW; Muñoz B; Ho A; Jha A; Michaelides M; Mohand-Said S; Cideciyan AV; Birch D; Hariri AH; Nittala MG; Sadda S; Scholl HPN;
JAMA Ophthalmol; 2017 Jul; 135(7):687-695. PubMed ID: 28542697
[TBL] [Abstract][Full Text] [Related]
11. The effect of light deprivation in patients with Stargardt disease.
Teussink MM; Lee MD; Smith RT; van Huet RA; Klaver CC; Klevering BJ; Theelen T; Hoyng CB
Am J Ophthalmol; 2015 May; 159(5):964-72.e2. PubMed ID: 25681002
[TBL] [Abstract][Full Text] [Related]
12. ULTRAWIDEFIELD AUTOFLUORESENCE IN ABCA4 STARGARDT DISEASE.
Klufas MA; Tsui I; Sadda SR; Hosseini H; Schwartz SD
Retina; 2018 Feb; 38(2):403-415. PubMed ID: 28248825
[TBL] [Abstract][Full Text] [Related]
13. Local progression kinetics of macular atrophy in recessive Stargardt disease.
Young BK; Zhao PY; Shen LL; Fahim AT; Jayasundera KT
Ophthalmic Genet; 2023 Dec; 44(6):539-546. PubMed ID: 37381907
[TBL] [Abstract][Full Text] [Related]
14. Early-onset stargardt disease: phenotypic and genotypic characteristics.
Lambertus S; van Huet RA; Bax NM; Hoefsloot LH; Cremers FP; Boon CJ; Klevering BJ; Hoyng CB
Ophthalmology; 2015 Feb; 122(2):335-44. PubMed ID: 25444351
[TBL] [Abstract][Full Text] [Related]
15. Quantitative fundus autofluorescence in recessive Stargardt disease.
Burke TR; Duncker T; Woods RL; Greenberg JP; Zernant J; Tsang SH; Smith RT; Allikmets R; Sparrow JR; Delori FC
Invest Ophthalmol Vis Sci; 2014 May; 55(5):2841-52. PubMed ID: 24677105
[TBL] [Abstract][Full Text] [Related]
16. Insights into autofluorescence patterns in Stargardt macular dystrophy using ultra-wide-field imaging.
Kumar V
Graefes Arch Clin Exp Ophthalmol; 2017 Oct; 255(10):1917-1922. PubMed ID: 28689222
[TBL] [Abstract][Full Text] [Related]
17. Near-infrared fundus autofluorescence in early age-related macular degeneration.
Battaglia Parodi M; Iacono P; Papayannis A; Alto G; Buzzotta A; Arrigo A; Cicinelli MV; Bandello F
Eur J Ophthalmol; 2020 Nov; 30(6):1448-1453. PubMed ID: 31661979
[TBL] [Abstract][Full Text] [Related]
18. Photoreceptor cells as a source of fundus autofluorescence in recessive Stargardt disease.
Paavo M; Lee W; Allikmets R; Tsang S; Sparrow JR
J Neurosci Res; 2019 Jan; 97(1):98-106. PubMed ID: 29701254
[TBL] [Abstract][Full Text] [Related]
19. Cone photoreceptor abnormalities correlate with vision loss in patients with Stargardt disease.
Chen Y; Ratnam K; Sundquist SM; Lujan B; Ayyagari R; Gudiseva VH; Roorda A; Duncan JL
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3281-92. PubMed ID: 21296825
[TBL] [Abstract][Full Text] [Related]
20. The absence of fundus abnormalities in Stargardt disease.
Bax NM; Lambertus S; Cremers FPM; Klevering BJ; Hoyng CB
Graefes Arch Clin Exp Ophthalmol; 2019 Jun; 257(6):1147-1157. PubMed ID: 30903310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
